764 results on '"Chang, Steven L."'
Search Results
2. Relationship between cigarette use and prostate cancer risk: what do we know and what should we do?
3. Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis
4. Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship
5. The Promise of Neoadjuvant and Adjuvant Therapies for Renal Cancer
6. The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage Analysis
7. The Impact of Venous Thromboembolism on Mortality and Morbidity During Nephrectomy for Renal Mass
8. Integrative clinical and molecular characterization of translocation renal cell carcinoma
9. MP53-04 NEOADJUVANT VERSUS ADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER: A DECISION ANALYSIS
10. PD44-09 DEFINING SUCCESS IN PYELOPLASTY PATIENTS TO GUIDE INITIAL POSTOPERATIVE FOLLOWUP
11. MP70-05 ADDRESSING DISPARITIES IN MODELING: DEVELOPMENT OF A RACIALLY FAIR ALGORITHM PREDICTING LYMPH NODE METASTASIS IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY
12. Determining Variable Costs in the Acute Urolithiasis Cycle of Care Through Time-Driven Activity-Based Costing
13. Cyclophosphamide-associated bladder cancers and considerations for survivorship care: A systematic review
14. Impact of inflammatory bowel disease on radical prostatectomy outcomes and costs of care
15. Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
16. Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
17. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy
18. Anticoagulation prophylaxis patterns following retroperitoneal lymph node dissection for testis cancer
19. Contemporary trends in percutaneous renal mass biopsy utilization in the United States
20. Association of Affordable Care Act-related Medicaid expansion with variation in utilization of surgical services
21. Alvimopan Is Associated With a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical Cystectomy
22. miR-218 Expressed in Endothelial Progenitor Cells Contributes to the Development and Repair of the Kidney Microvasculature
23. Institutional trends and safety profile of same-day discharge for robot-assisted laparoscopic radical prostatectomy: A retrospective analysis
24. Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical Cystectomy
25. Differences in survival and impact of adjuvant chemotherapy in patients with variant histology of tumors of the renal pelvis
26. Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma
27. Response of Primary Renal Cell Carcinoma to Systemic Therapy
28. Hospital Charges for Urologic Surgery Episodes of Care Are Rising Despite Declining Costs
29. How Have Hospital Pricing Practices for Surgical Episodes of Care Responded to Affordable CareAct-Related Medicaid Expansion?
30. Postradical prostatectomy prostate‐specific antigen outcomes after 6 versus 18 months of perioperative androgen‐deprivation therapy in men with localized, unfavorable intermediate‐risk or high‐risk prostate cancer: Results of part 2 of a randomized phase 2 trial
31. Post-renal Acute Kidney Injury: Epidemiology, Presentation, Pathophysiology, Diagnosis, and Management
32. Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes
33. Preoperative anemia is associated with increased radical cystectomy complications
34. Systematic Review of the Volume–Outcome Relationship for Radical Prostatectomy
35. Use of Preventive Health Services Among Cancer Survivors in the U.S.
36. Factors Influencing Prostate Specific Antigen Testing in the United States
37. Comparative Effectiveness of Transurethral Resection Techniques in the Inpatient Setting for Benign Prostatic Hyperplasia
38. Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy
39. The Receipt of Industry Payments is Associated With Prescribing Promoted Alpha-blockers and Overactive Bladder Medications
40. Current Staging Strategies for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma
41. Cost and cost-effectiveness studies in urologic oncology using large administrative databases
42. Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA
43. Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories
44. Trends in penile prosthesis implantation and analysis of predictive factors for removal
45. Exploring Patterns of Mitomycin C Use in Community Practice Urology
46. Robotic-assisted radical cystectomy is associated with lower perioperative mortality in octogenarians
47. The national utilization of nonoperative management for small renal masses over 10 years
48. Abstract PR015: Tumor-specific immunity generated by a personalized neoantigen vaccination incorporating locally delivered ipilimumab in renal cell carcinoma
49. Abstract A013: Tumor-specific immunity generated by a personalized neoantigen vaccination incorporating locally delivered ipilimumab in renal cell carcinoma
50. Prophylactic Antibiotics and Postoperative Complications of Radical Cystectomy: A Population Based Analysis in the United States
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.